XGN
Price:
$4.54
Market Cap:
$109.69M
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of autoimmune and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its flagship product, AVISE CTD, aids in distinguishing between various connective tissue diseases (CTDs) and other conditions with overlapping symptoms in symptomatic patients. The company's product portfolio includes AVISE Lupus, which assesse...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-09-19
Stock Exchange
NASDAQ
Ticker
XGN
According to Exagen Inc.’s latest financial reports and current stock price. The company's current ROE is -113.53%. This represents a change of 296.79% compared to the average of -28.61% of the last 4 quarters.
The mean historical ROE of Exagen Inc. over the last ten years is 17.62%. The current -113.53% ROE has changed -744.34% with respect to the historical average. Over the past ten years (40 quarters), XGN's ROE was at its highest in in the March 2019 quarter at 670.97%. The ROE was at its lowest in in the March 2025 quarter at -58.60%.
Average
17.62%
Median
-35.75%
Minimum
-158.44%
Maximum
552.63%
Discovering the peaks and valleys of Exagen Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 539.08%
Maximum Annual ROE = 552.63%
Minimum Annual Increase = -118.18%
Minimum Annual ROE = -158.44%
| Year | ROE | Change |
|---|---|---|
| 2025 | -114.34% | -27.83% |
| 2024 | -158.44% | 51.78% |
| 2023 | -104.38% | -6.47% |
| 2022 | -111.60% | 253.03% |
| 2021 | -31.61% | -20.74% |
| 2020 | -39.88% | 84.41% |
| 2019 | -21.63% | -118.18% |
| 2018 | 118.98% | -78.47% |
| 2017 | 552.63% | 539.08% |
| 2015 | 86.47% | -18.87% |
The current ROE of Exagen Inc. (XGN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-125.72%
5-year avg
-104.08%
10-year avg
17.62%
Exagen Inc.’s ROE is greater than NeoGenomics, Inc. (-11.82%), less than MDxHealth S.A. (402.97%), greater than Aclaris Therapeutics, Inc. (-55.89%), greater than Stereotaxis, Inc. (-153.21%), greater than Sanara MedTech Inc. (-246.44%), greater than Sight Sciences, Inc. (-59.10%), greater than Alpha Teknova, Inc. (-24.32%), greater than BioAge Labs, Inc. (-29.40%), greater than Lifecore Biomedical, Inc. (-176.12%), greater than Vanda Pharmaceuticals Inc. (-61.41%),
| Company | ROE | Market cap |
|---|---|---|
| -11.82% | $289.85M | |
| 402.97% | $27.89M | |
| -55.89% | $542.68M | |
| -153.21% | $183.74M | |
| -246.44% | $201.79M | |
| -59.10% | $287.28M | |
| -24.32% | $280.94M | |
| -29.40% | $781.98M | |
| -176.12% | $207.80M | |
| -61.41% | $348.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exagen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Exagen Inc.'s ROE?
How is the ROE calculated for Exagen Inc. (XGN)?
What is the highest ROE for Exagen Inc. (XGN)?
What is the 3-year average ROE for Exagen Inc. (XGN)?
What is the 5-year average ROE for Exagen Inc. (XGN)?
How does the current ROE for Exagen Inc. (XGN) compare to its historical average?